Eudendron Srl - Company Review
SummaryEudendron Srl - Company Review
Summary
Eudendron Srl (Eudendron) is a drug discovery company that develops inhibitors. The company develops kinase inhibitors for therapies to treat cancer and other oncology related diseases. Its molecular designs generate compounds that inhibit kinase mutated forms. Eudendron’s molecular design technology platform provides solution to drug resistance and modulates selectivity profile across large kinase panel and optimizes kinase drug delivery process. The company’s EUD-GK-91 is a novel compound for preventing drug resistance in treatment of non small cell lung cancer. It also offers resource for preparation and screening of compound collections. Eudendron is headquartered in Varese, Italy.
This comprehensive company report of Eudendron Srl provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.